Clinical Trial Update: Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors. [NA]

View source ↗

Summary

The completed trial evaluates whether circulating monocytes can serve as a predictive biomarker for cystic fibrosis and assesses the impact of CFTR correctors o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cystic Fibrosis | NA | Status: COMPLETED